{
    "nctId": "NCT00668174",
    "briefTitle": "Effect of Exercise on Sex Hormones in Postmenopausal Women",
    "officialTitle": "Physical Activity and Total Health Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Prevention",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 173,
    "primaryOutcomeMeasure": "Serum total estrone concentration",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ages 55-75 years at first group meeting\n* Physically able to undertake a moderate exercise program\n* Sedentary activity pattern (exercising \\< 2 times/week for 20 minutes at a level to produce sweating)\n* Postmenopausal (not experiencing menstrual periods for the previous 12 months or FSH \\>30 mIU/ml; for women who have had a hysterectomy, an FHS \\>30 mIU/ml will classify them as postmenopausal)\n* Body Mass Index (BMI) greater than 25.0\n* Able to follow directions and fill out questionnaires, and exercise diaries and logs in English\n* Agrees to be randomly assigned to either the exercise intervention or control group\n* Gives informed consent to participate in all screening and study activities\n* Able to come to the FHCRC for clinic visits and classes, to the UW Medical Center for CT scans, and to the UW NETT for measurements and instruction\n\nExclusion Criteria:\n\n* Plans to leave Western Washington within the follow-up period\n* Using hormone replacement, tamoxifen, or oral contraceptives in past 6 months\n* Currently having severe hot flashes (that might prompt participant to start hormone replacement therapy before the end of study)\n* Current unstable thyroid disease or unstable dose of thyroid medications or TSH \\>5.0 IU/ml or \\<0.5 IU/ml\n* Invasive cancer in the past 10 years (except nonmelanotic skin cancer)\n* Any other endocrinologic abnormality\n* Breast, endometrial, ovarian, or melanoma cancer or carcinoma-in-situ at any time\n* Morbidly obese (BMI \\> 40)\n* Current or planned use of corticosteroids\n* Currently on or planning to enter a structured weight loss program or to take diet drugs\n* Current use of certain other medications, such as any likely to interfere with adherence to an exercise program or likely to interfere with study outcomes\n* Moderate to high alcohol intake (more than 2 drinks per day)\n* Current smoker\n* Diabetes mellitus (fasting hyperglycemia)\n* Abnormal screening labs (hematocrit \\< 32 or \\> 48, white blood cells \\< 3.0 or \\> 15.0, potassium \\< 3.5 or \\> 5.0, fasting glucose \\> 140, creatinine \\> 2.0), or abnormalities on screening physical judged by study physicians to contraindicate participation in an exercise program\n* Contraindications for entry into a training program118 including: unstable angina, uncontrolled hypertension (systolic \\> 200, diastolic \\> 100), orthostatic hypotension (\\> 20), moderate/severe aortic stenosis, uncontrolled arrhythmia, uncontrolled congestive heart failure, third degree heart block, pericarditis, myocarditis, pulmonary/systemic embolism within the past 6 months, thrombophlebitis, ST displacement \\> 3 mm at rest, history of cardiac arrest)\n* Contraindications for exercise testing118 including: recent (within 6 months) cardiac event (MI, pulmonary edema, myocarditis, pericarditis), unstable angina, uncontrolled arrhythmia, third degree heart block, left bundle branch block, acute congestive failure, recent (within 6 months) pulmonary/systemic embolus, severe electrolyte abnormality\n* Meets criteria to stop screening exercise test118 as decided by overseeing physician (Dr. Schwartz or McTiernan)\n* volunteering in order to lose weight\n* alcohol or drug abuse, significant mental illness (as assessed by study staff impression)",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}